It targets the "innate repair receptor" (IRR) to turn off pain signals and promote nerve healing and myelination [7]
doi: 10.1016/j.molimm.2024.07.004 133 IdosaB
To learn how this ties into broader systemic recovery, see Unlocking the Healing Power of BPC-157: Benefits, Uses, and Science Explained
doi: 10.1016/j.heliyon.2023.e16764 127 YangT.WangR.LiuH.WangL.LiJ.WuS.et al
Common IGF-1 LR3 IM dose context (research planning, not clinical guidance) Phase Assessment Daily dose 20 mcg/day Site Trained muscle, post-workout Notes Identical glucose-monitoring rules apply as with SubQ
The consideration of cysteine during these simulations were important, as cytosolic cysteine is the rate limiting amino acid precursor for synthesis of GSH, via the -glutamylcysteine synthetase (GCS) enzyme, and this is a function of its reduced concentration compared to the other precursors, glycine and glutamate